Corticosteroid Regulation of Gonadotropin Secretion and Induction of Ovulation in the Rat

Darrell W Brann, Carla D. Putnam, Virendra B. Mahesh

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

In the human polycystic ovarian syndrome, glucocorticoids have been demonstrated to have beneficial effects in inducing ovulation in a number of cases. These beneficial effects were assumed to be due to suppression of adrenal overproduction of androgens. However, the possibility exists that glucocorticoids may directly regulate gonadotropin secretion and thereby improve menstrual rhythm and ovulatory activity. Herein, we report that the corticoid, deoxycorticosterone, and the synthetic glucocorticoid, triamcinolone acetonide, like progesterone (P4), are able to induce luteinizing hormone and follicle-stimulating hormone surges and facilitate ovulation in the pregnant mare serum gonadotropin-primed rat. This effect is not shared by cortisol. Prolactin release was also stimulated by deoxycorticosterone, cortisol, and progesterone, but not by triamcinolone acetonide. Similar to progesterone, triamcinolone acetonide and deoxycorticosterone administration caused a loss of fluid retention in the uterus. This effect of triamcinolone acetonide and deoxycorticosterone may be related to progesterone action as opposed to antiinflammatory action since cortisol had no effect on uterine fluid retention. These findings raise the possibility that the beneficial effects seen with glucocorticoids in inducing ovulation in polycystic ovarian syndrome may be due in part to their direct effects upon the release of gonadotropins.

Original languageEnglish (US)
Pages (from-to)176-180
Number of pages5
JournalProceedings of the Society for Experimental Biology and Medicine
Volume193
Issue number3
DOIs
StatePublished - Jan 1 1990

Fingerprint

Triamcinolone Acetonide
Desoxycorticosterone
Ovulation Induction
Gonadotropins
Glucocorticoids
Progesterone
Rats
Adrenal Cortex Hormones
Ovulation
Hydrocortisone
Polycystic Ovary Syndrome
Equine Gonadotropins
Fluids
Follicle Stimulating Hormone
Luteinizing Hormone
Prolactin
Androgens
Uterus
Anti-Inflammatory Agents

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Corticosteroid Regulation of Gonadotropin Secretion and Induction of Ovulation in the Rat. / Brann, Darrell W; Putnam, Carla D.; Mahesh, Virendra B.

In: Proceedings of the Society for Experimental Biology and Medicine, Vol. 193, No. 3, 01.01.1990, p. 176-180.

Research output: Contribution to journalArticle

@article{80a3ef3a637b410493a85b69605d91a3,
title = "Corticosteroid Regulation of Gonadotropin Secretion and Induction of Ovulation in the Rat",
abstract = "In the human polycystic ovarian syndrome, glucocorticoids have been demonstrated to have beneficial effects in inducing ovulation in a number of cases. These beneficial effects were assumed to be due to suppression of adrenal overproduction of androgens. However, the possibility exists that glucocorticoids may directly regulate gonadotropin secretion and thereby improve menstrual rhythm and ovulatory activity. Herein, we report that the corticoid, deoxycorticosterone, and the synthetic glucocorticoid, triamcinolone acetonide, like progesterone (P4), are able to induce luteinizing hormone and follicle-stimulating hormone surges and facilitate ovulation in the pregnant mare serum gonadotropin-primed rat. This effect is not shared by cortisol. Prolactin release was also stimulated by deoxycorticosterone, cortisol, and progesterone, but not by triamcinolone acetonide. Similar to progesterone, triamcinolone acetonide and deoxycorticosterone administration caused a loss of fluid retention in the uterus. This effect of triamcinolone acetonide and deoxycorticosterone may be related to progesterone action as opposed to antiinflammatory action since cortisol had no effect on uterine fluid retention. These findings raise the possibility that the beneficial effects seen with glucocorticoids in inducing ovulation in polycystic ovarian syndrome may be due in part to their direct effects upon the release of gonadotropins.",
author = "Brann, {Darrell W} and Putnam, {Carla D.} and Mahesh, {Virendra B.}",
year = "1990",
month = "1",
day = "1",
doi = "10.3181/00379727-193-43021",
language = "English (US)",
volume = "193",
pages = "176--180",
journal = "Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)",
issn = "1535-3702",
publisher = "Society for Experimental Biology and Medicine",
number = "3",

}

TY - JOUR

T1 - Corticosteroid Regulation of Gonadotropin Secretion and Induction of Ovulation in the Rat

AU - Brann, Darrell W

AU - Putnam, Carla D.

AU - Mahesh, Virendra B.

PY - 1990/1/1

Y1 - 1990/1/1

N2 - In the human polycystic ovarian syndrome, glucocorticoids have been demonstrated to have beneficial effects in inducing ovulation in a number of cases. These beneficial effects were assumed to be due to suppression of adrenal overproduction of androgens. However, the possibility exists that glucocorticoids may directly regulate gonadotropin secretion and thereby improve menstrual rhythm and ovulatory activity. Herein, we report that the corticoid, deoxycorticosterone, and the synthetic glucocorticoid, triamcinolone acetonide, like progesterone (P4), are able to induce luteinizing hormone and follicle-stimulating hormone surges and facilitate ovulation in the pregnant mare serum gonadotropin-primed rat. This effect is not shared by cortisol. Prolactin release was also stimulated by deoxycorticosterone, cortisol, and progesterone, but not by triamcinolone acetonide. Similar to progesterone, triamcinolone acetonide and deoxycorticosterone administration caused a loss of fluid retention in the uterus. This effect of triamcinolone acetonide and deoxycorticosterone may be related to progesterone action as opposed to antiinflammatory action since cortisol had no effect on uterine fluid retention. These findings raise the possibility that the beneficial effects seen with glucocorticoids in inducing ovulation in polycystic ovarian syndrome may be due in part to their direct effects upon the release of gonadotropins.

AB - In the human polycystic ovarian syndrome, glucocorticoids have been demonstrated to have beneficial effects in inducing ovulation in a number of cases. These beneficial effects were assumed to be due to suppression of adrenal overproduction of androgens. However, the possibility exists that glucocorticoids may directly regulate gonadotropin secretion and thereby improve menstrual rhythm and ovulatory activity. Herein, we report that the corticoid, deoxycorticosterone, and the synthetic glucocorticoid, triamcinolone acetonide, like progesterone (P4), are able to induce luteinizing hormone and follicle-stimulating hormone surges and facilitate ovulation in the pregnant mare serum gonadotropin-primed rat. This effect is not shared by cortisol. Prolactin release was also stimulated by deoxycorticosterone, cortisol, and progesterone, but not by triamcinolone acetonide. Similar to progesterone, triamcinolone acetonide and deoxycorticosterone administration caused a loss of fluid retention in the uterus. This effect of triamcinolone acetonide and deoxycorticosterone may be related to progesterone action as opposed to antiinflammatory action since cortisol had no effect on uterine fluid retention. These findings raise the possibility that the beneficial effects seen with glucocorticoids in inducing ovulation in polycystic ovarian syndrome may be due in part to their direct effects upon the release of gonadotropins.

UR - http://www.scopus.com/inward/record.url?scp=0025391052&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025391052&partnerID=8YFLogxK

U2 - 10.3181/00379727-193-43021

DO - 10.3181/00379727-193-43021

M3 - Article

C2 - 2106139

AN - SCOPUS:0025391052

VL - 193

SP - 176

EP - 180

JO - Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)

JF - Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)

SN - 1535-3702

IS - 3

ER -